Extracellular levels of brain aspartate, glutamate and GABA during an inhibitory avoidance response in the rat

被引:20
作者
Ballini, Chiara [1 ]
Della Corte, Laura [1 ]
Pazzagli, Marta [1 ]
Colivicchi, Maria Alessandra [1 ]
Pepeu, Giancarlo [1 ]
Tipton, Keith F. [2 ]
Giovannini, Maria Grazia [2 ]
机构
[1] Univ Florence, Dipartimento Farmacol Preclin & Clin M Aiazzi Man, Florence, Italy
[2] Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland
关键词
amino acids; medial prefrontal cortex; microdialysis; step-down task; ventral hippocampus;
D O I
10.1111/j.1471-4159.2008.05452.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The extracellular levels of aspartate, glutamate and GABA were measured by microdialysis, coupled with an HPLC method, in rat prefrontal cortex (mPFC) and ventral hippocampus (VH) before and during the performance of a step-down inhibitory task. The basal levels of glutamate were about 50% higher than those of aspartate, and GABA levels were about 20-folds smaller than those of the excitatory amino acids. There were no significant differences in the basal levels of any of the three amino acids between the two brain regions. The extracellular levels of aspartate increased during acquisition and recall trials in both VH and mPFC, whereas those of glutamate increased in the VH during acquisition only. A significant increase in GABA levels was also detected during acquisition but only in the mPFC. The neuronal origin of the increased extracellular levels of aspartate, glutamate and GABA was demonstrated by administering tetrodotoxin directly into the mPFC or VH by reverse dialysis. These findings, together with previous evidence from our and other laboratories, indicate a differential release of aspartate and glutamate from excitatory neurons during the performance of behavioral responses, and therefore, distinct roles for the two excitatory amino acids should be envisaged.
引用
收藏
页码:1035 / 1043
页数:9
相关论文
共 32 条
[11]   Changes in dialysate concentrations of glutamate and GABA in the brain: an index of volume transmission mediated actions? [J].
Del Arco, A ;
Segovia, G ;
Fuxe, K ;
Mora, F .
JOURNAL OF NEUROCHEMISTRY, 2003, 85 (01) :23-33
[12]  
Dingledine Raymond, 1999, P315
[13]   THE NEUROTRANSMITTER AMINO-ACID TRANSPORT-SYSTEMS - A FRESH OUTLOOK ON AN OLD PROBLEM [J].
ERECINSKA, M .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (21) :3547-3555
[14]   Increased levels of D-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility [J].
Errico, Francesco ;
Nistico, Robert ;
Palma, Giuseppe ;
Federici, Mauro ;
Affuso, Andrea ;
Brilli, Elisa ;
Topo, Enza ;
Centonze, Diego ;
Bernardi, Giorgio ;
Bozzi, Yuri ;
D'Aniello, Antimo ;
Di Lauro, Roberto ;
Mercuri, Nicola B. ;
Usiello, Alessandro .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2008, 37 (02) :236-246
[15]   M1 muscarinic receptor stimulation decreases aspartate release in the rat neostriatum [J].
Exposito, I ;
Sanz, B ;
Mora, F .
NEUROCHEMICAL RESEARCH, 1997, 22 (12) :1485-1490
[16]   A dual probe characterization of dialysate amino acid levels in the medial prefrontal cortex and ventral tegmental area of the awake freely moving rat [J].
Frantz, K ;
Harte, M ;
Ungerstedt, U ;
O'Connor, WT .
JOURNAL OF NEUROSCIENCE METHODS, 2002, 119 (02) :109-119
[17]   Inhibition of acetylcholine-induced activation of extracellular regulated protein kinase prevents the encoding of an inhibitory avoidance response in the rat [J].
Giovannini, MG ;
Pazzagli, M ;
Malmberg-Aiello, P ;
Della Corte, L ;
Rakovska, AD ;
Cerbai, F ;
Casamenti, F ;
Pepeu, G .
NEUROSCIENCE, 2005, 136 (01) :15-32
[18]   Effects of novelty and habituation on acetylcholine, GABA, and glutamate release from the frontal cortex and hippocampus of freely moving rats [J].
Giovannini, MG ;
Rakovska, A ;
Benton, RS ;
Pazzagli, M ;
Bianchi, L ;
Pepeu, G .
NEUROSCIENCE, 2001, 106 (01) :43-53
[19]  
Gundersen V, 1998, J NEUROSCI, V18, P6059
[20]   Nicotine increases microdialysate brain amino acid concentrations and induces conditioned place preference [J].
Kashkin, VA ;
De Witte, P .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 (06) :625-632